FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794855819> ?p ?o ?g. }

• W2794855819 endingPage "203" @default.
• W2794855819 startingPage "198" @default.
• W2794855819 abstract "In Brief Multidrug-resistant (MDR) gram-negative bacterial infection is a serious and growing public health threat, in part due to limited treatment options. A novel cephalosporin and β-lactamase inhibitor, ceftolozane/tazobactam, has a broad spectrum of activity against MDR pathogens and is approved for the treatment of complicated intra-abdominal infections in combination with metronidazole and complicated urinary tract infections, including pyelonephritis. This article reviews published data on the clinical pharmacology, spectrum of activity, pharmacokinetics/pharmacodynamics, clinical efficacy and safety, and dosing and administration of ceftolozane/tazobactam. Searches of MEDLINE from January 2000 to April 2017 were conducted using the following keywords: ceftolozane, tazobactam, and ceftolozane tazobactam. Additional references were identified from a review of the retrieved articles' citations. Ceftolozane is active against organisms producing AmpC β-lactamases and MDR Pseudomonas aeruginosa. The addition of tazobactam enhances activity against extended-spectrum β-lactamase–producing organisms. Data from phase III trials using ceftolozane/tazobactam for the treatment of complicated intra-abdominal infection and complicated urinary tract infections have yielded positive results. Ceftolozane/tazobactam has demonstrated noninferior or superior efficacy to comparators in clinical trials. It has a favorable safety profile and few drug-drug interactions. This novel combination agent has a role in treating MDR infections, particularly P. aeruginosa, although its use should be reserved for patients without other treatment options to limit the risk of resistance. Although case reports of successful treatment have been reported, further investigation is needed into the utility of ceftolozane/tazobactam for the treatment of bacteremia and pneumonia caused by MDR pathogens. Ceftolozane/tazobactam has demonstrated noninferior or superior efficacy to comparators in clinical trials. This novel combination agent has a role in treating multidrug-resistant infections at multiple sites of infection, particularly infections caused by Pseudomonas aeruginosa. This review highlights the intricacies of use of ceftolozane/tazobactam for multidrug-resistant infections." @default.
• W2794855819 created "2018-04-06" @default.
• W2794855819 creator A5070941653 @default.
• W2794855819 creator A5077091691 @default.
• W2794855819 creator A5088539653 @default.
• W2794855819 date "2018-07-01" @default.
• W2794855819 modified "2023-10-18" @default.
• W2794855819 title "A Review of Ceftolozane/Tazobactam for the Treatment of Infections Caused by Multidrug-Resistant Pathogens" @default.
• W2794855819 cites W1969500929 @default.
• W2794855819 cites W1970599332 @default.
• W2794855819 cites W1976078168 @default.
• W2794855819 cites W1983892079 @default.
• W2794855819 cites W1989886020 @default.
• W2794855819 cites W1994992293 @default.
• W2794855819 cites W2010231427 @default.
• W2794855819 cites W2041384752 @default.
• W2794855819 cites W2108985755 @default.
• W2794855819 cites W2117970531 @default.
• W2794855819 cites W2125354275 @default.
• W2794855819 cites W2129842338 @default.
• W2794855819 cites W2146291304 @default.
• W2794855819 cites W2170292564 @default.
• W2794855819 cites W2299301903 @default.
• W2794855819 cites W2307357170 @default.
• W2794855819 cites W2462059638 @default.
• W2794855819 cites W2511984556 @default.
• W2794855819 cites W2515632632 @default.
• W2794855819 cites W2524275130 @default.
• W2794855819 cites W2528498234 @default.
• W2794855819 cites W2620266053 @default.
• W2794855819 cites W4255310200 @default.
• W2794855819 doi "https://doi.org/10.1097/ipc.0000000000000638" @default.
• W2794855819 hasPublicationYear "2018" @default.
• W2794855819 type Work @default.
• W2794855819 sameAs 2794855819 @default.
• W2794855819 citedByCount "5" @default.
• W2794855819 countsByYear W27948558192020 @default.
• W2794855819 countsByYear W27948558192022 @default.
• W2794855819 countsByYear W27948558192023 @default.
• W2794855819 crossrefType "journal-article" @default.
• W2794855819 hasAuthorship W2794855819A5070941653 @default.
• W2794855819 hasAuthorship W2794855819A5077091691 @default.
• W2794855819 hasAuthorship W2794855819A5088539653 @default.
• W2794855819 hasConcept C177713679 @default.
• W2794855819 hasConcept C2777637488 @default.
• W2794855819 hasConcept C2778266534 @default.
• W2794855819 hasConcept C2779631663 @default.
• W2794855819 hasConcept C501593827 @default.
• W2794855819 hasConcept C523546767 @default.
• W2794855819 hasConcept C54355233 @default.
• W2794855819 hasConcept C71924100 @default.
• W2794855819 hasConcept C86803240 @default.
• W2794855819 hasConcept C89423630 @default.
• W2794855819 hasConcept C94665300 @default.
• W2794855819 hasConcept C98274493 @default.
• W2794855819 hasConceptScore W2794855819C177713679 @default.
• W2794855819 hasConceptScore W2794855819C2777637488 @default.
• W2794855819 hasConceptScore W2794855819C2778266534 @default.
• W2794855819 hasConceptScore W2794855819C2779631663 @default.
• W2794855819 hasConceptScore W2794855819C501593827 @default.
• W2794855819 hasConceptScore W2794855819C523546767 @default.
• W2794855819 hasConceptScore W2794855819C54355233 @default.
• W2794855819 hasConceptScore W2794855819C71924100 @default.
• W2794855819 hasConceptScore W2794855819C86803240 @default.
• W2794855819 hasConceptScore W2794855819C89423630 @default.
• W2794855819 hasConceptScore W2794855819C94665300 @default.
• W2794855819 hasConceptScore W2794855819C98274493 @default.
• W2794855819 hasIssue "4" @default.
• W2794855819 hasLocation W27948558191 @default.
• W2794855819 hasOpenAccess W2794855819 @default.
• W2794855819 hasPrimaryLocation W27948558191 @default.
• W2794855819 hasRelatedWork W1562163838 @default.
• W2794855819 hasRelatedWork W2358528625 @default.
• W2794855819 hasRelatedWork W2371748164 @default.
• W2794855819 hasRelatedWork W2400984801 @default.
• W2794855819 hasRelatedWork W2422697752 @default.
• W2794855819 hasRelatedWork W2897214732 @default.
• W2794855819 hasRelatedWork W2992296290 @default.
• W2794855819 hasRelatedWork W2995170042 @default.
• W2794855819 hasRelatedWork W3132092684 @default.
• W2794855819 hasRelatedWork W4361190065 @default.
• W2794855819 hasVolume "26" @default.
• W2794855819 isParatext "false" @default.
• W2794855819 isRetracted "false" @default.
• W2794855819 magId "2794855819" @default.
• W2794855819 workType "article" @default.